Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243696 · ClinicalTrials.gov registry record
Protego DF4 Post Approval Registry
A clinical trial, sponsored by Biotronik.
- Terminated
- Registry status
- 1,694
- Enrollment target
NCT02243696: Clinical Trial study, sponsored by Biotronik.
NCT02243696 is a clinical trial that was terminated before completion, run by Biotronik. The registered enrollment target is 1,694 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02243696 was terminated before completion, sponsored by Biotronik.
- TERMINATED
- Registry status
- 1,694 participants
- Enrollment target
Study Summary
The purpose of this registry study is to confirm the long-term safety and reliability of the Protego DF4 right ventricular lead.
Primary Outcome
Evaluate the percentage of subjects without an adverse event related to the Protego DF4 lead or header through 5 years. The endpoint is analyzed as the adverse event free-rate.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,694 participants |
| Start Date | 2014-09-27 |
| Est. Completion | 2019-04-17 |
Why NCT02243696 stopped before completion
NCT02243696 is an observational study that tracks outcomes without assigning an intervention. Its 1,694 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02243696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02243696 about?
NCT02243696 is a clinical study titled "Protego DF4 Post Approval Registry". The purpose of this registry study is to confirm the long-term safety and reliability of the Protego DF4 right ventricular lead.
What is the current status of trial NCT02243696?
This trial is currently terminated. The enrollment target is 1,694 participants. The study started on 2014-09-27. Estimated completion is 2019-04-17.
Who is sponsoring clinical trial NCT02243696?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI